ACG Capsules Introduces New Line of HPMC Capsules
The ACGcaps H+ capsules work to meet pharmaceutical and nutraceutical needs while remaining gelatin-free.
ACG Capsules introduced the ACGcaps H+ capsule for pharmaceutical and nutraceutical needs on Aug. 19, 2019. The new line of hydroxypropyl methyl cellulose (HPMC) capsules are pH-independent, non-ionic, work without a gelling agent, and are suitable for hygroscopic and moisture-sensitive formulations.
The capsules comply with the requirements of dissolution performances across all biological pH ranges while working to reduce cross-linking problems, which occur with gelatin-based capsules and cause a limited dissolution performance.ACGcaps H+ capsules can also be used for filling granules, powders, pellets for prescription and non-prescription pharmaceutical ingredients, nutraceutical dietary supplements, and traditional medicines.
“The new and enhanced range of HPMC capsules is designed to give pharma and nutraceutical customers added peace of mind by providing product protection and desired formulation release. The new line contains no gelatin, wheat, gluten, animal by-products, or starch, making it ideal for supporting clean label claims and vegetarian diets,”said Selwyn Noronha, CEO for ACG Capsules, in a company press release.
Source: ACG Capsules
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.
